Lanzhou Foci Pharmaceutical Co Ltd Net Asset Momentum
Lanzhou Foci Pharmaceutical Co Ltd net asset momentum. Lanzhou Foci Pharmaceutical Co Ltd (002644) recorded a net asset momentum of 2.6% as of December 2024, with net assets of CN¥1.81 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore 002644 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)
Net asset momentum of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. This chart tracks Lanzhou Foci Pharmaceutical Co Ltd's year-over-year net asset growth across 18 annual reporting periods from 2007 to 2024. The most recent momentum reading is +2.6%, with net assets of CN¥1.81 Billion CNY as of December 2024. See Lanzhou Foci Pharmaceutical Co Ltd (002644) net assets for net asset value and shareholders' equity analysis.
Lanzhou Foci Pharmaceutical Co Ltd Net Asset Momentum by Year (2007–2024)
Lanzhou Foci Pharmaceutical Co Ltd net asset momentum by year from 2007 to 2024. The table below shows the complete annual net asset history for Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024, covering 18 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Lanzhou Foci Pharmaceutical Co Ltd (002644) total market value.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.81 Billion | CN¥2.47 Billion | CN¥654.81 Million | ▲ +2.6% |
| 2023 | CN¥1.77 Billion | CN¥2.53 Billion | CN¥759.67 Million | ▲ +2.0% |
| 2022 | CN¥1.73 Billion | CN¥2.59 Billion | CN¥852.60 Million | ▲ +6.5% |
| 2021 | CN¥1.63 Billion | CN¥2.35 Billion | CN¥724.59 Million | ▲ +2.5% |
| 2020 | CN¥1.59 Billion | CN¥2.39 Billion | CN¥800.08 Million | ▲ +5.3% |
| 2019 | CN¥1.51 Billion | CN¥2.40 Billion | CN¥893.78 Million | ▲ +4.6% |
| 2018 | CN¥1.44 Billion | CN¥2.52 Billion | CN¥1.08 Billion | ▲ +6.0% |
| 2017 | CN¥1.36 Billion | CN¥2.35 Billion | CN¥990.68 Million | ▲ +5.3% |
| 2016 | CN¥1.29 Billion | CN¥2.04 Billion | CN¥746.13 Million | ▲ +4.6% |
| 2015 | CN¥1.23 Billion | CN¥1.36 Billion | CN¥128.77 Million | ▲ +67.8% |
| 2014 | CN¥735.22 Million | CN¥1.05 Billion | CN¥311.40 Million | ▲ +4.5% |
| 2013 | CN¥703.37 Million | CN¥903.08 Million | CN¥199.70 Million | ▲ +4.1% |
| 2012 | CN¥675.53 Million | CN¥822.91 Million | CN¥147.38 Million | ▲ +4.2% |
| 2011 | CN¥648.08 Million | CN¥829.23 Million | CN¥181.14 Million | ▲ +98.5% |
| 2010 | CN¥326.46 Million | CN¥456.16 Million | CN¥129.70 Million | ▲ +29.1% |
| 2009 | CN¥252.96 Million | CN¥422.05 Million | CN¥169.09 Million | ▲ +16.7% |
| 2008 | CN¥216.81 Million | CN¥400.52 Million | CN¥183.70 Million | ▲ +11.1% |
| 2007 | CN¥195.20 Million | CN¥359.92 Million | CN¥164.72 Million | — |